Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jessica Haberer, M.D.

Concepts (479)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jessica Haberer's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jessica Haberer has written about over time.
Antiretroviral Therapy, Highly Active, 23 publications between 2006 and 2023, average publication date June 2015. Reminder Systems, 13 publications between 2010 and 2024, average publication date July 2016. Anti-Retroviral Agents, 46 publications between 2005 and 2023, average publication date May 2017. Medication Adherence, 118 publications between 2009 and 2024, average publication date February 2018. Uganda, 143 publications between 2010 and 2024, average publication date February 2018. Sexual Partners, 32 publications between 2012 and 2024, average publication date March 2018. Anti-HIV Agents, 140 publications between 2007 and 2024, average publication date March 2018. HIV Infections, 243 publications between 2006 and 2024, average publication date May 2018. Qualitative Research, 30 publications between 2010 and 2024, average publication date October 2019. Tuberculosis, 20 publications between 2002 and 2024, average publication date May 2020. South Africa, 34 publications between 2013 and 2024, average publication date September 2020. Latent Tuberculosis, 6 publications between 2021 and 2024, average publication date December 2022. Sexually Transmitted Diseases, 9 publications between 2020 and 2024, average publication date January 2023.

To see the data from this visualization as text, click here.
Haberer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (479)
Explore
_
Co-Authors (87)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.